Impaired Barrier Integrity of the Skeletal Muscle Vascular Endothelium Drives Progression of Cancer Cachexia
Preprint
- 19 December 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Cancer patients experience cachexia, which is characterized by extensive skeletal muscle wasting that worsens the quality of life and increases mortality. Currently, there are no approved treatments that can effectively counteract cancer cachexia. Vascular endothelial cells (ECs) are essential for maintaining tissue perfusion, nutrient supply, and preventing inappropriate transmigration of immune cells into the tissue. However, little is known about the role of the muscle vasculature in cancer cachexia. We hypothesized that endothelial dysfunction in the skeletal muscle mediates cancer cachexia. Using transgenic pancreatic ductal adenocarcinoma (PDAC) mice and a tissue clearing and high-resolution 3D-tissue imaging approach, we found that the loss of skeletal muscle vascular density precedes the loss of muscle mass. Importantly, we show that cancer cachexia patients exhibit significantly decreased muscle vascular density and severe muscle atrophy when compared to non-cancer patients. Unbiased single cell transcriptomic analyses of the muscle endothelium unveiled a unique EC population present in cachexia muscles. Increased circulating Activin-A suppresses the expression of the transcriptional co-activator PGC1α in the muscle endothelium, thus disrupting junctional integrity in the vasculature and increasing vascular leakage. Conversely, restoration of endothelial-specific PGC1α prevented the decreased vascular density and muscle loss observed in tumor-bearing mice. Our study suggests that endothelial PGC1α is essential for maintaining the integrity of the skeletal muscle vascular barrier and that restoring muscle endothelial function could be a valuable therapeutic approach to prevent or reverse cancer cachexia.Keywords
All Related Versions
- Version 1, 2022-12-19, Research Square
- Published version: Nature Cancer, 6 (8), 1350.
This publication has 77 references indexed in Scilit:
- The contributory role of vascular health in age‐related anabolic resistanceJournal of Cachexia, Sarcopenia and Muscle, 2021
- Sex Differences in Cancer CachexiaCurrent Osteoporosis Reports, 2020
- pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to ExerciseCell, 2020
- Single-Cell Transcriptome Atlas of Murine Endothelial CellsCell, 2020
- The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapyJournal of Cachexia, Sarcopenia and Muscle, 2019
- Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responsesJournal of Cachexia, Sarcopenia and Muscle, 2018
- Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular AgingCell, 2018
- The Hippo Pathway Kinases LATS1/2 Suppress Cancer ImmunityCell, 2016
- A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle HypertrophyCell, 2012
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005